Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
L. J. Aponte-Collazo, E. M. J. Fennell, M. P. East…·L. M. Graves
This paper shows that ClpP activators induce senescence in triple-negative breast cancer cells and enhance their sensitivity to TRAIL-mediated apoptosis.
R. E. Turn, Y. Hu, S. I. Dewees…·R. A. Kahn
This study identifies ELMOD1 and ELMOD3 as regulators of ciliogenesis and ciliary protein traffic, with phenotypes similar to ELMOD2 deletion but distinct in their effects on Golgi-ciliary transport.
C. Asquith, K. Naegeli, M. P. East…·D. C. Morris
The paper designs a set of GAK/EGFR inhibitors to study their relationship in chordoma and characterizes their activity in vitro and through target engagement assays.
C. R. M. Asquith, B.-T. Berger, J. Wan…·W. J. Zuercher
The paper describes SGC-GAK-1, a selective GAK inhibitor, and identifies a related compound that inhibits RIPK2 without GAK activity, providing tools to study GAK and RIPK2 biology.
K. A. Collins, T. J. Stuhlmiller, J. S. Zawistowski…·S. M. Gomez
The paper uses proteomic analysis to define kinase taxonomies specific to breast cancer subtypes, revealing understudied kinases and their functional integration into signaling subnetworks.